The expression of BMP, integrin, ZEB2 in ovarian high-grade serous carcinoma in relation with lymph node metastasis

被引:1
|
作者
Zirh, Elham Bahador [1 ,2 ]
Kapakli, Elif Tasar [3 ]
Dolgun, Anil [4 ]
Usubutun, Alp [3 ]
Zeybek, Naciye Dilara [2 ]
机构
[1] TOBB Econ & Technol Univ, Fac Med, Dept Histol & Embryol, Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Histol & Embryol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Pathol, Ankara, Turkey
[4] RMIT Univ, Dept Math Sci, Melbourne, Vic, Australia
关键词
High-grade ovarian cancer; lymph node metastasis; BMP2; BMP7; integrin alpha 5; integrin beta 1; ZEB2; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; GENE-EXPRESSION; BREAST-CANCER; TGF-BETA; BONE; INHIBITION; PROTEINS; SURVIVAL;
D O I
10.1080/08977194.2022.2099849
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ovarian cancer (OC) is clinically important because it is diagnosed late and has metastasis when it is diagnosed. Mortality risk increases 2.75 times in the presence of lymph node (LN) metastasis. During metastasis, many molecules including BMPs originated from stroma, and tumor cells participate through transcription factors and integrins for cytoskeleton regulation during cell migration. We hypothesized an inverse correlation between BMP2 and BMP7 along with changes in ZEB2, and integrin alpha 5 beta 1 in high-grade OCs in relation to LN metastasis. The BMP2 immunoreactivity was strong along with strong ZEB2 and weak integrins' immunoreactivity in samples with LN metastasis. Strong immunoreactivity of BMP7 was accompanied by strong immunoreactivity of integrins in the samples without LN metastasis. Study results showed BMP2's strong positive immunoreactivity and weak BMP7 immunoreactivity in tumor cells with a significantly weak inverse correlation. This inverse correlation should be considered as both BMPs have different effects in the window of cancer progression and invasion.
引用
收藏
页码:153 / 162
页数:10
相关论文
共 50 条
  • [21] Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
    Verhaak, Roel G. W.
    Tamayo, Pablo
    Yang, Ji-Yeon
    Hubbard, Diana
    Zhang, Hailei
    Creighton, Chad J.
    Fereday, Sian
    Lawrence, Michael
    Carter, Scott L.
    Mermel, Craig H.
    Kostic, Aleksandar D.
    Etemadmoghadam, Dariush
    Saksena, Gordon
    Cibulskis, Kristian
    Duraisamy, Sekhar
    Levanon, Keren
    Sougnez, Carrie
    Tsherniak, Aviad
    Gomez, Sebastian
    Onofrio, Robert
    Gabriel, Stacey
    Chin, Lynda
    Zhang, Nianxiang
    Spellman, Paul T.
    Zhang, Yiqun
    Akbani, Rehan
    Hoadley, Katherine A.
    Kahn, Ari
    Koebel, Martin
    Huntsman, David
    Soslow, Robert A.
    Defazio, Anna
    Birrer, Michael J.
    Gray, Joe W.
    Weinstein, John N.
    Bowtell, David D.
    Drapkin, Ronny
    Mesirov, Jill P.
    Getz, Gad
    Levine, Douglas A.
    Meyerson, Matthew
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (01) : 517 - 525
  • [22] HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival
    Davidson, Ben
    Holth, Arild
    Hellesylt, Ellen
    Hadar, Rivka
    Katz, Betina
    Trope, Claes G.
    Reich, Reuven
    HUMAN PATHOLOGY, 2016, 48 : 95 - 101
  • [23] Prostaglandin D2 expression is prognostic in high-grade serous ovarian cancer
    Alves, Mariana Rezende
    Do Amaral, Nayra Soares
    Marchi, Fabio Albuquerque
    De Barros Silva, Felipe Ilelis
    Balieiro Anastacio Da Costa, Alexandre Andre
    Carvalho, Katia Candido
    Baiocchi, Glauco
    Soares, Fernando Augusto
    De Brot, Louise
    Rocha, Rafael Malagoli
    ONCOLOGY REPORTS, 2019, 41 (04) : 2254 - 2264
  • [24] Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes
    Murakami, Ryusuke
    Matsumura, Noriomi
    Mandai, Masaki
    Yoshihara, Kosuke
    Tanabe, Hiroshi
    Nakai, Hidekatsu
    Yamanoi, Koji
    Abiko, Kaoru
    Yoshioka, Yumiko
    Hamanishi, Junzo
    Yamaguchi, Ken
    Baba, Tsukasa
    Koshiyama, Masafumi
    Enomoto, Takayuki
    Okamoto, Aikou
    Murphy, Susan K.
    Mori, Seiichi
    Mikami, Yoshiki
    Minamiguchi, Sachiko
    Konishi, Ikuo
    AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (05) : 1103 - 1113
  • [25] miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma
    Dong, Ruifen
    Liu, Xiaolin
    Zhang, Qing
    Jiang, Zhijun
    Li, Yingwei
    Wei, Yuyan
    Li, Yinuo
    Yang, Qifeng
    Liu, Jinsong
    Wei, Jian-Jun
    Shao, Changshun
    Liu, Zhaojian
    Kong, Beihua
    ONCOTARGET, 2014, 5 (21) : 10816 - 10829
  • [26] Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)
    Talhouk, Aline
    George, Joshy
    Wang, Chen
    Budden, Timothy
    Tan, Tuan Zea
    Chiu, Derek S.
    Kommoss, Stefan
    Leong, Huei San
    Chen, Stephanie
    Intermaggio, Maria P.
    Gilks, Blake
    Nazeran, Tayyebeh M.
    Volchek, Mila
    Elatre, Wafaa
    Bentley, Rex C.
    Senz, Janine
    Lum, Amy
    Chow, Veronica
    Sudderuddin, Hanwei
    Mackenzie, Robertson
    Leong, Samuel C. Y.
    Liu, Geyi
    Johnson, Dustin
    Chen, Billy
    Alsop, Jennifer
    Banerjee, Susana N.
    Behrens, Sabine
    Bodelon, Clara
    Brand, Alison H.
    Brinton, Louise
    Carney, Michael E.
    Chiew, Yoke-Eng
    Cushing-Haugen, Kara L.
    Cybulski, Cezary
    Ennis, Darren
    Fereday, Sian
    Fortner, Renee T.
    Garcia-Donas, Jesus
    Gentry-Maharaj, Aleksandra
    Glasspool, Rosalind
    Goranova, Teodora
    Greene, Casey S.
    Haluska, Paul
    Harris, Holly R.
    Hendley, Joy
    Hernandez, Brenda Y.
    Herpel, Esther
    Jimenez-Linan, Mercedes
    Karpinskyj, Chloe
    Kaufmann, Scott H.
    CLINICAL CANCER RESEARCH, 2020, 26 (20) : 5411 - 5423
  • [27] Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma
    Matsuo, Koji
    Sheridan, Todd B.
    Mabuchi, Seiji
    Yoshino, Kiyoshi
    Hasegawa, Kosei
    Studeman, Kimberley D.
    Im, Dwight D.
    Rosenshein, Neil B.
    Roman, Lynda D.
    Sood, Anil K.
    GYNECOLOGIC ONCOLOGY, 2014, 133 (03) : 473 - 479
  • [28] Assessment of the differences in oncologic outcomes between patients with high-grade serous ovarian carcinoma and uterine serous carcinoma
    Kilic, Fatih
    Ersak, Burak
    Cakir, Caner
    Yuksel, Dilek
    Kilic, Cigdem
    Korkmaz, Vakkas
    Tokgozoglu, Nedim
    Toptas, Tayfun
    Boran, Nurettin
    Comert, Gunsu Kimyon
    Ureyen, Isin
    Tasci, Tolga
    Tekin, Ozlem Moraloglu
    Ustun, Yaprak
    Turan, Taner
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2024, 50 (01) : 86 - 94
  • [29] PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma
    Spear, Sarah
    Le Saux, Olivia
    Mirza, Hasan B.
    Iyer, Nayana
    Tyson, Katie
    Freile, Fabio Grundland
    Walton, Josephine B.
    Woodman, Chloe
    Jarvis, Sheba
    Ennis, Darren P.
    Hernandez, Carmen Aguirre
    Xu, Yuewei
    Spiliopoulou, Pavlina
    Brenton, James D.
    Costa-Pereira, Ana P.
    Cook, David P.
    Vanderhyden, Barbara C.
    Keun, Hector C.
    Triantafyllou, Evangelos
    Arnold, James N.
    Mcneish, Iain A.
    CANCER RESEARCH, 2024, 84 (22) : 3772 - 3787
  • [30] Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
    Cooke, S. L.
    Ng, C. K. Y.
    Melnyk, N.
    Garcia, M. J.
    Hardcastle, T.
    Temple, J.
    Langdon, S.
    Huntsman, D.
    Brenton, J. D.
    ONCOGENE, 2010, 29 (35) : 4905 - 4913